0000914190-21-000214.txt : 20210810 0000914190-21-000214.hdr.sgml : 20210810 20210810182044 ACCESSION NUMBER: 0000914190-21-000214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210810 DATE AS OF CHANGE: 20210810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlow Brenda S. CENTRAL INDEX KEY: 0001443851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 211161383 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-06 0000842023 BIO-TECHNE Corp TECH 0001443851 Furlow Brenda S. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 SVP - General Counsel Common Stock 2021-08-08 4 M 0 1374 0 A 7498 D Common Stock 2021-08-08 4 F 0 677 481.82 D 6821 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 921 921 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 3538 3538 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 9503 9503 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 12670 12670 D Restricted Stock Units 2021-08-08 4 M 0 1374 0 D Common Stock 1374 0 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 7339 7339 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 9786 9786 D Restricted Stock Units Common Stock 1969 1969 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 9968 9968 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 13290 13290 D Restricted Stock Units Common Stock 1679 1679 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 7492 7492 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 9990 9990 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 8325 8325 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 8325.0 8325.0 D Stock Options (Right to Buy) 372.44 2022-08-31 2028-03-01 Common Stock 10997 10997 D Restricted Stock Units 2021-08-06 4 A 0 1167 0 A Common Stock 1167 1167 D Stock Options (Right to Buy) 481.82 2021-08-06 4 A 0 4560 0 A 2028-08-06 Common Stock 4560 4560 D Stock Options (Right to Buy) 481.82 2021-08-06 4 A 0 6080 0 A 2028-08-06 Common Stock 6080 6080 D Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Fully exercisable. Vested in full on 8/8/2021 upon the certification of achievement of performance goals. Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. /s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed. 2021-08-10